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Abstract
Cellodextrins are non-digestible oligosaccharides that have attracted interest from the food industry as potential prebiotics. They
are typically produced through the partial hydrolysis of cellulose, resulting in a complex mixture of oligosaccharides with a
varying degree of polymerisation (DP). Here, we explore the defined synthesis of cellotriose as product since this oligosaccharide
is believed to be the most potent prebiotic in the mixture. To that end, the cellobiose phosphorylase (CBP) from Cellulomonas
uda and the cellodextrin phosphorylase (CDP) fromClostridium cellulosiwere evaluated as biocatalysts, starting from cellobiose
and α-D-glucose 1-phosphate as acceptor and donor substrate, respectively. The CDP enzyme was shown to rapidly elongate the
chains towards higher DPs, even after extensive mutagenesis. In contrast, an optimised variant of CBP was found to convert
cellobiose to cellotriose with a molar yield of 73%. The share of cellotriose within the final soluble cellodextrin mixture (DP2-5)
was 82%, resulting in a cellotriose product with the highest purity reported to date. Interestingly, the reaction could even be
initiated from glucose as acceptor substrate, which should further decrease the production costs.
Key points
• Cellobiose phosphorylase is engineered for the production of cellotriose.
• Cellotriose is synthesised with the highest purity and yield to date.
• Both cellobiose and glucose can be used as acceptor for cellotriose production.
Keywords Enzyme engineering . Cellotriose synthesis . Prebiotic . Cellobiose phosphorylase
Introduction
Oligosaccharides have continuously growing applications in the
food, feed and pharmaceutical industries (Han et al. 2012;Meyer
et al. 2015; Martins et al. 2019). In particular, non-digestible
oligosaccharides can serve as prebiotics that promote immune-
modulatory health effects by influencing the gut microbiome
composition (Panesar and Bali 2015; Holscher 2017; Wu et al.
2017). Examples of prebiotics that are already well established
on the market include fructooligosaccharides (FOS),
galactooligosaccharides (GOS), soybean-derived oligosaccha-
rides (SOS) and (arabino)xylooligosaccharides (XOS/AXOS)
(Gibson 2008; Pokusaeva et al. 2011; Anadón et al. 2015;
Carlson and Slavin 2016). This prebiotic pool will surely expand
further as research focusing on the role of prebiotics continues to
stimulate the market, which is predicted to grow to approximate-
ly $10.55 billion by 2025 (Research and Markets 2019).
Cellooligosaccharides are composed of D-glucose mono-
mers that are linked by a β-1,4-glycosidic bond and can,
therefore, not be degraded by the human digestive enzymes.
They are getting increasing attention as low-caloric fibres and
potential prebiotics, as well as additives in pharmaceutical
products (Rojas 2016). The common production route for
cellodextrins is the chemical degradation of cellulose, the
most abundant organic polymer on Earth (Klemm et al.
2005). Enzymatic alternatives include hydrolysis by cellulases
(Kobayashi et al. 1991; Horn et al. 2012) or synthesis by
phosphorylases (Luley-Goedl and Nidetzky 2010; Desmet
and Soetaert 2012; Nakai et al. 2013). Regardless of the
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production method, the result typically is a mixture of carbo-
hydrate chains with a varying degree of polymerisation (DP)
(Mano et al. 2018).
The disaccharide cellobiose has already been produced
in large amounts by the combined action of sucrose phos-
phorylase (SP; EC 2.4.1.7) and cellobiose phosphorylase
(CBP; EC 2.4.1.20) (Koch et al. 2016) (Fig. 1). In this
two-step, one-pot reaction, α-D-glucose 1-phosphate
(αG1-P) serves as a high-energy intermediate that is con-
tinuously being regenerated in situ from sucrose (Koch
et al. 2016) (Fig. 1). More recently, cellobiose elongation
towards cellodextrins was achieved by adding cellodextrin
phosphorylase (CDP; EC 2.4.1.49) to the reaction (Zhong
et al. 2019). A maximal product concentration of 26 g/L
was reported, and the resulting cellodextrin mixture
consisted of DP2-6 at a ratio of 8/23/36/24/9 (Zhong
et al. 2019). However, the production of the defined
cellooligosaccharide with a high yield and purity remains
challenging, which is unfortunate as cellotriose is the pre-
ferred substrate for Bifidobacterium breve UCC2003, a
dominant probiotic bacterium in a healthy intestinal mi-
crobiota (Pokusaeva et al. 2011).
Here, we explored the possibility of engineering CDP
and CBP for the defined synthesis of cellotriose.
Although the synthetic reaction of CBP is the production
of cellobiose from glucose and αG1-P (Fig. 1), a litera-
ture search revealed a previously created CBP variant
that also showed activity on cellobiose as acceptor and
was named OCP2 for its phosphorolytic activity on octyl
β-cellobioside (De Groeve et al. 2010a). In this work,
the products obtained by cellobiose elongation were de-
termined, and semi-rational mutagenesis was applied,
resulting in a CBP variant that provides the highest yield
and purity of cellotriose reported to date. Furthermore,




All chemicals were obtained from Sigma-Aldrich (St. Louis,
MO, USA) or Merck (Darmstadt, Germany), unless noted oth-
erwise and were of the highest purity. Cellooligosaccharides of
DP2-6 were obtained from Carbosynth (Compton, UK) or
Megazyme (Bray, Ireland). The Escherichia coli BL21(DE3)
strain was obtained fromNewEngland Biolabs (Beverly, USA).
Gene cloning and transformation
The OCP2 variant of cellobiose phosphorylase from
Cellulomonas uda (CuCBP_OCP2) (De Groeve et al. 2010a)
was ordered as a synthetic gene from GeneArt and cloned in
the isopropyl β-D-1-thio-galactopyranoside (IPTG) inducible
pET21a plasmid with ampicillin resistance and N-terminal
His6-tag. The cellodextrin phosphorylase from Clostridium
cellulosi (CcCDP) was provided by the Austrian Center of
Industrial Biotechnology, Graz, Austria, in their in-house de-
signed constitutive plasmid (pC21e1) with ampicillin resistance
and N-terminal His6-tag (Zhong et al. 2019). To avoid αG1-P
degradation, the acid glucose 1-phosphatase gene (agp) was
knocked-out of the E. coli BL21(DE3) strain using the
recombinase/flippase gene disruption protocol (Datsenko and
Wanner 2000). The final construct (E. coli BL21(DE3) agp−)
was verified by sequencing (Macrogen) and used for transfor-
mation and heterologous expression of all enzymes.
Site-directed mutagenesis
Site-directed mutations were introduced with a modified two-
stage megaprimer-based whole-plasmid PCR method (Sanchis
et al. 2008). The PCR mix contained 0.05 U/μl PfuUltra high-
fidelity DNA polymerase (Stratagene, La Jolla, USA), 0.2 mM
Fig. 1 Reaction scheme of cellobiose (CBP) and cellodextrin phosphorylase (CDP). The in situ production of the high-energy intermediate α-D-glucose
1-phosphate (αG1-P) from sucrose is depicted in grey
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dNTP mix, 2 ng/μl template and 0.1 pmol/μl of each primer
(Supplementary Table S1) in a total volume of 50 μl. The pro-
gram started with an initial denaturation (3 min at 94 °C) follow-
ed by 5 cycles of denaturation for 30 s at 94 °C, annealing for
1 min at 55 °C and extension for 1 min/kb (size megaprimer) at
72 °C. The second stage consisted of 30 cycles of 10 s at 94 °C
and extension for 1min/kb (size entire plasmid) at 72 °C, follow-
ed by one final extension of 2 min at 72 °C. After digestion by
DpnI (Westburg, Leusden, The Netherlands), PCR products
were purified by innuPREP PCRpure Kit (Analytik Jena, Jena,
Germany). The plasmids were transformed in E. coli
BL21(DE3) agp− electrocompetent cells and subjected to nucle-
otide sequencing (Macrogen, Amsterdam, The Netherlands) af-
ter a plasmid mini-prep (Analytik Jena, Jena, Germany).
Protein expression and cell lysis
Overnight cultures of CBP and CDP variants were inoculated
(1% v/v) in 200 ml lysogeny broth (LB) containing 100 μg/ml
ampicillin in 1-L shake flasks and incubated at 30 °C with con-
tinuous shaking at 200 rpm. Cultures were grown until the
OD600 reached 0.6, and the enzyme production of CBP variants
was induced by adding IPTG to a final concentration of 0.1mM.
Next, the culture was incubated overnight at 30 °C with contin-
uous shaking at 200 rpm. The expression of CDP variants was
achieved without induction due to a constitutive promoter. Cells
were then collected by centrifugation, and the cell pellet was
frozen at − 20 °C for at least 4 h. To obtain the enzyme, the cell
pellet was slowly thawed on ice and resuspended in 10 ml lysis
buffer composed out of 1 mg/ml of lysozyme (from chicken egg
white), 100 μM phenylmethylsulfonyl fluoride (PMSF) and
50 mM 3-(N-morpholino)propanesulfonic acid (MOPS) at
pH 7. Subsequently, the cells were sonicated three times for
3 min (Branson Sonifier 250, level 3, 50% duty cycle) or
homogenised by glass beads (homogeniser FastPrep-24TM,
MP Bio): 1.5 ml of glass beads were added to the lysate, and
the mix was homogenised for 4 cycles of 30 s (4.0 m/s). Cell
debris was removed by centrifugation at 4500 rpm for 30 min at
4 °C. Unless stated otherwise, the resulting crude cell extract was
used for all reactions. Alternatively, the enzyme was further
purified by a nickel-nitrilotriacetic acid (Ni-NTA) chromatogra-
phy according to supplier’s protocol (MCLab, San Francisco,
USA), after which the buffer was exchanged to 50 mM MOPS
(pH 7) in a 30-kDa Amicon Ultra centricon using a 30 kDa cut-
off (Merck Millipore, Darmstadt, Germany). The protein con-
centration was measured using the BCA Protein Assay kit
(Pierce, Thermo Fisher Scientific, Waltham, MA, USA) with
bovine serum albumin (BSA) as a standard.
Cellooligosaccharide screening
The soluble cellooligosaccharides were separated and quanti-
fied by high-performance anion-exchange chromatography
with a pulsed amperometric detection (HPAEC-PAD;
Dionex ICS-3000 system, Thermo Fisher Scientific,
Waltham, MA, USA), using a gradient method (0–11 min
100 mM NaOH, 11–20 min 90% 100 mM NaOH and 10%
100 mM NaOH/100 mM NaOAc, followed by 20–26 min
100% 100 mM NaOH for recalibration) and a flow rate of
0.5 ml/min. Analytical standards with different concentrations
of αG1-P, glucose, cellobiose, cellotriose, cellotetraose and
cellopentaose were used to detect and perform a quantitative
analysis of cellodextrins. The results were visualised and plot-
ted in SigmaPlot software (Systat Software Inc.).
Reaction conditions and screening of mutants
To estimate whether CcCDP mutations result in a modified
product profile, 3.5–4 mg/ml of protein crude cell extract was
added into the reaction, and the outcome was evaluated after
4 h at 30 °C and pH 7. To follow cellooligosaccharide forma-
tion and substrate consumption with OCP2 variants, 6–
7 mg/ml of crude cell extract was added into each enzymatic
reaction, with varying substrate concentrations, and the out-
come was followed over time at 40 °C and pH 7. Samples
were inactivated by a 5-min incubation in a heat-block at
100 °C, and the denatured enzyme was removed by centrifu-
gation for 5 min at 13500 rpm. Next, the samples were diluted
1500-fold in ultrapure water and analysed by HPAEC-PAD.
The specific activity of the OCP2 variants was determined
with respect to cellotriose production over time by using crude
cell extracts, in 50 mMMOPS pH 7 at 40 °C. Cellotriose was
quantified based on the HPAEC-PAD peak areas and using
the analytical standard (0–50 μM).
Fig. 2 Docking of cellotetraose in subsite − 1/+ 3 of the CcCDP
homology model. The residues targeted for site-directed mutagenesis
are represented in light blue (Table S2)
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Enzyme kinetics
Unless stated otherwise, the activity was monitored in the
synthetic direction by measuring the release of inorganic
phosphate by the phosphomolybdate assay (Gawronski and
Benson 2004; DeGroeve et al. 2010b). One unit of the activity
is defined as the amount of enzyme that generates 1 μmol of
product per min under the used conditions. To determine the
kinetic parameters of CcCDP variants, the reactions were per-
formed with crude cell extracts in 100 mM 2-(N-
morpholino)ethanesulfonic acid (MES) at pH 7 andmonitored
at 55 °C during 12 min. Samples of 100 μl were taken every
2 min for two acceptor concentrations (10 mM and 400 mM
cellobiose with 50 mM αG1-P as a donor substrate). To de-
termine the kinetic parameters of OCP2 and OCP2_M52R,
the reactions were performed with purified enzymes in
50 mM MOPS at pH 7 and monitored at 40 °C for 12 min
(with acceptor glucose or cellobiose) or 40 min (with acceptor
cellotriose). Samples were taken every 2 or 5 min for each
acceptor concentration (5–450 mM glucose; 5–250 mM cel-
lobiose; 10–70mM cellotriose, with 100 mMαG1-P as donor
substrate). All samples were inactivated by the acidic condi-
tions of the assay solution or by heating for 5 min at 100 °C
and analysed with the phosphomolybdate assay to quantify
the released phosphate. The kinetic parameters were calculat-
ed from Lineweaver-Burk linear regression (for CcCDP vari-
ants) and Michaelis-Menten non-linear regression (for OCP2
and OCP2_M52R) using SigmaPlot (Systat Software Inc.).
The molecular weight of 111.6 kDa and 91.4 kDa was used
to calculate the turnover number (kcat) for CcCDP and OCP2
variants, respectively.
Ligand docking, homology modelling and sequence
alignments
The homology models of the OCP2 and OCP2_M52R vari-
ants, as well as CcCDP, were generated with YASARA
(Krieger and Spronk 2013; Land and Humble 2018) using
default parameters. Template crystal structures for homology
modelling were automatically selected by YASARA based on
the highest scores. For OCP2 and OCP2_M52R, the enzyme
structure of CBP from Cellumonas uda (CuCBP) served as a
template: 3S4A (PDB entry). For CcCDP, the enzyme struc-
ture of CDP from Clostridium thermocellum (CtCDP) was
used as a template: 5NZ7 (PDB entry). The CuCBP_OCP2
homology model and the crystal structures of CuCBP and
CtCDP co-crystallised with cellobiose and cellotetraose, re-
spectively, were aligned in YASARA by the built-in
MUSTANG algorithm (Konagurthu et al. 2006; Krieger and
Spronk 2013; Land and Humble 2018). Figures were made
using PyMOL v2.0 (Schrödinger 2018 LLC, New York,
USA). The reaction scheme of CBP and CDP was prepared
in the ChemDraw program (PerkinElmer Informatics). The
amino acid sequences were aligned in Clustal Omega
webserver (Sievers and Higgins 2018) and manually curated
based on the structural alignment.
Sequence accession number
The sequences of CuCBP, CtCDP and CcCDP (UniProt iden-
tifiers: Q7WTR6, Q93HT8 and A0A078KL08, respectively)
can be found in GenBank under accession numbers
AAQ20920.1, BAB71818.1 and CDZ24361.1 for amino acid
sequences, and AY343322.1, AB061316.1 and LM995447.1
for the nucleotide sequences, respectively.
Table 1 Optimal cellodextrin
composition obtained with OCP2
and CcCDP (values are reported
for the time points indicated with




















CcCDP 69 25 28 16 19 16 18
OCP2 82 64 74 5 6 – –
a The molar yield is calculated based on cellobiose consumption
b The purity is reported within the DP2-5 mixture
– not detected
Fig. 3 Active site of the CuCBP_OCP2 homology model with docked
cellotetraose (in red). The residues targeted for site-directed mutagenesis
are represented in green cyan (Table 2)
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Results
Engineering of cellodextrin phosphorylase
The reported process for the controlled synthesis of water-
soluble cellodextrins (DP2-6) was developed using the
cellodextrin phosphorylase from Clostridium cellulosi
(CcCDP) as biocatalyst (Zhong et al. 2019; Zhong and
Nidetzky 2019). A strategy was now devised to shift this
enzyme’s spectrum towards cellotriose as the main product.
More specifically, it was envisaged that limiting substrate
binding in subsite + 3 should stop chain elongation at DP3.
To identify suitable positions for mutagenesis, a homology
model of CcCDP was constructed, and cellotetraose was
docked in subsites − 1 to + 3 (Fig. 2). Larger residues were
introduced with the aim of blocking subsite + 3, whereas sub-
stitutions to smaller amino acids like alanine could potentially
remove stabilizing interactions with cellotriose as an acceptor.
In the end, nine single-point variants were prepared and
recombinantly expressed in E. coli (Fig. 2, Supplementary
Table S2). Unfortunately, the analysis of their reactions by
HPAEC-PAD revealed that none of the mutations resulted in
a significantly modified product profile (not shown) and al-
most all had a negative impact on the specific activity
(Supplementary Table S2).
Cellobiose phosphorylase as alternative biocatalyst
CBP and CDP both belong to the glycoside hydrolase 94
(GH94) enzyme family and, hence, share a number of struc-
tural features (Nakajima et al. 2017). However, CBP has a
more closed active site that comprises only two subsites
(− 1/+ 1) (Hai Tran et al. 2011). We, therefore, speculated that
cellobiose phosphorylase might be a more suitable starting
point for engineering towards cellotriose production.
Previously engineered CBP variant from Cellulomonas uda
(CuCBP_OCP2 or OCP2) that contained the five following
mutations: N163D, N156D, T508I, E649G and N667A
(Fig. 6c) exhibited synthetic activity on cellobiose (De
Groeve et al. 2010a). Although the enzyme’s kinetics has been
reported, the products obtained by cellobiose elongation have
not yet been determined (De Groeve et al. 2010a).
Interestingly, an initial comparison of OCP2 with CcCDP not
only demonstrated that OCP2 produces cellooligosaccharides,
but also that it has a clear preference for cellotriose formation
(Fig. 4a). A maximal conversion of 82% of cellobiose was ob-
served, with cellotriose accounting for about 74% of the soluble
cellodextrins (Table 1, Fig. 4a). Moreover, the cellotriose molar
yield was around 2.5-fold higher with OCP2 compared to that of
CcCDP (Table 1). As the reaction progresses, the enzyme starts
to use the longer oligosaccharides as an acceptor, hence not
consuming cellobiose beyond this point (Fig. 4a). Although the
OCP2 variant did not exhibit a complete preference for
cellotriose, its product profile certainly is much more promising
than that of CcCDP.
Further engineering of OCP2
To identify target residues for further engineering of the OCP2
variant, a detailed analysis of its sequence and structure was
conducted. A highly conserved aromatic residue at the + 2 sub-
site of CDP has been previously identified as specificity finger-
print that discriminates between CDP and CBP (Hai Tran et al.
2011). An alignment of CuCBP and CcCDP indeed shows that
Table 2 Screening of different
OCP2 variants (specific activity
was measured during 4–5 h (1.5 h
for OCP2_M52R) using crude
cell extracts, 100 mM cellobiose
and 400 mM αG1-P, at pH 7 and
40 °C; one unit of the activity is
defined as the amount of the en-











OCP2 0.04 95 76 16
OCP2_D156W Inactive – – –
OCP2_D156Y 0.01 81 70 3
OCP2_D156R 0.03 97 77 18
OCP2_D156K 0.04 ± 0.02 99 69 27
OCP2_M52W 0.01 97 77 17
OCP2_M52R 0.16 89 82 3
OCP2_K51R 0.07 ± 0.01 93 74 15
OCP2_G502N 0.02 90 65 12
OCP2_R166Y Inactive – – –
a Standard deviations are calculated based on triplicates and were ≤ 10%, unless stated otherwise
b All samples were taken after 22 h when approximately all variants reached the maximal cellobiose conversion,
except for OCP2_M52R that reached the maximal conversion after 4 h
c The purity is reported within the DP2-5 mixture
– not determined
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Fig. 4 Cellodextrin formation with different enzyme variants at pH 7 and
40 °C. The arrow indicates the time point for which concentrations are
listed in the tables. a OCP2 (left) and CcCDP (right), using 100 mM
cellobiose and 200 mM αG1-P (Table 1). b OCP2_M52R (left) and
OCP2 (right), using 100 mM cellobiose and 400 mM αG1-P (Table 3).
c OCP2_M52R (left) and OCP2 (right), using 100 mM glucose and
400 mM αG1-P (Table 3). The data are from single representative
time-course experiment but are within ≤ 10% for replicates (N ≤ 3)
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the latter contains an aromatic residue at this position (Y301)
whereas the former contains an Arg residue (R166) (Fig. 3,
Fig. 5). The corresponding substitution has now been introduced
in OCP2 (R166Y) to evaluate the impact on cellotriose synthesis
(Table 2). The mutation, however, resulted in a completely inac-
tive enzyme (Table 2), highlighting the high evolutionary signif-
icance of this residue for CBP activity.
Docking of cellotetraose in the active site, the OCP2 model
highlighted M52, D156, K51 and G502 as the most interesting
target residues for further mutagenesis (Fig. 3). Eight different
variants were thus created, of which M52R turned out to be the
best one. Indeed, this mutation resulted in the highest cellotriose
formation (82%) and the lowest cellotetraose accumulation (3%),
as well as a fourfold increase in specific activity (from 0.04 to
0.16 U mg−1) (Table 2). Since all other variants displayed fea-
tures that were overall not better than those of the template en-
zyme, only OCP2_M52R was characterised in detail.
Detailed characterisation of OCP2_M52R
To further elucidate the differences between OCP2 and
OCP2_M52R concerning cellotriose synthesis, reactions
with a 0.25 M ratio of cellobiose/αG1-P were followed
over time (Fig. 4b, Table 3). An excess of αG1-P was
used to push the enzymes towards the synthesis of longer
cellodextrins, thus challenging OCP2_M52R’s preference
towards cellotriose production. Moreover, it has been pre-
viously reported that the molar ratio of acceptor/αG1-P
was the main variable affecting the produced DPs with
both CBP and CDP (Zhong et al. 2019). When 200 mM
αG1-P was used, the production of soluble cellodextrins
from glucose required this ratio to be 0.25 or lower
(Zhong et al. 2019).
The maximal conversion of cellobiose to cellodextrins was
similar with both variants, namely about 87% (Fig. 4b, Table 3).
The reaction with OCP2_M52R, however, resulted in a 2.5-fold
lower yield of cellotetraose compared to OCP2 and slightly
higher yield (73% vs 62%) and purity (82% vs 79%) of
cellotriose, thus confirming the previous findings (Table 2).
Both variants were further evaluated concerning the products
synthesised from glucose, which is considerably cheaper than
cellobiose as acceptor (Fig. 4b, Table 3). The results again
showed that OCP2_M52R performs better with the purity of
cellotriose, reachingmaximal 62%, contrary to the 48% achieved
with OCP2 (Table 3). Although the maximal conversion of cel-
lobiose was similar with both variants, OCP2_M52R was slight-
lymore efficient in converting glucose (91%) compared toOCP2
(86%) (Table 3).
To further elucidate the differences between OCP2 and its
variant M52R, a detailed kinetic characterisation was conducted
(Table 4). The results showed that the latter has a fourfold lower
Michaelis-Menten constant (Km) for cellobiose, while theKm for
cellotriosewas not significantly affected (Table 4). Both enzymes
exhibited a higher affinity for cellobiose than for glucose
(Table 4). With cellobiose as an acceptor, the catalytic efficiency
of OCP2_M52R was around sevenfold higher than that of
OCP2. When glucose and cellotriose were used as acceptors,
the catalytic efficiency was similar in both variants.
Table 3 Optimal cellodextrin composition obtained with OCP2 and OCP2_M52R (values are reported for the time points indicated with an arrow in
Fig. 4b, c; DP2-cellobiose, DP3-cellotriose, DP4-cellotetraose, DP5-cellopentaose)
Enzyme Acceptor Conversion (%) DP2
molar
yield (%)a

















OCP2_M52R Cellobiose 86 – – 73 82 2 2 – –
OCP2 Cellobiose 88 – – 62 79 5 7 0.05 0.06
OCP2_M52R Glucose 91 26 27 62 62 2 2 – –
OCP2 Glucose 86 28 32 42 48 3 3 – –
a The molar yield is calculated based on acceptor consumption
b The purity is reported within the DP1–5 (with glucose as acceptor) or DP2-5 (with cellobiose as acceptor)
– not detected
Table 4 Kinetic parameters on different acceptors (using 100 mM αG1-P, at pH 7 and 40 °C)



















OCP2 19.0 ± 2.1 1.9 ± 0.0 100.0 ± 23.8 10.2 ± 0.8 1.2 ± 0.0 117.6 ± 21.1 5.3 ± 1.7 0.06 ± 0.003 11.3 ± 1.7
OCP2_M52R 43.8 ± 4.0 4.7 ± 0.1 107.3 ± 25.0 2.3 ± 0.6 2.0 ± 0.1 869.6 ± 166.7 5.4 ± 1.6 0.05 ± 0.003 9.2 ± 1.8
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Discussion
An efficient process has recently been reported for the
controlled synthesis of soluble cellooligosaccharides
(DP2-6) from glucose in a combined enzymatic reaction
with SP, CBP and CDP (Zhong et al. 2019). However,
cellotriose accounted for only 23% of the product mixture,
which is consistent with the results obtained here with just
CDP as biocatalyst (cellotriose purity of 28%). In an at-
tempt to disrupt subsite + 3 of CcCDP and hamper further
chain elongation, nine single-point mutants were created.
As none of these showed a modified product profile, it was
concluded that the active site cleft of CDP is most likely
too spacious to interfere with acceptor binding through a
simple amino acid substitution. Extensive remodelling of
the active site (e.g., by loop insertions) could be attempted,
but that typically is a very challenging undertaking with a
minimal chance of success. A better starting point was
found in the cellobiose phosphorylase variant OCP2,
which was previously shown to use cellobiose as acceptor
but had not yet been characterised in detail. This biocata-
lyst offered a 2.5-fold higher yield (64% vs 25%) and pu-
rity (74% vs 28%) of cellotriose compared to CcCDP. It
should be noted that a fraction of the acceptor substrate is
converted to longer cellooligosaccharides that precipitate
out of the reaction mixture due to their low solubility.
To provide an explanation for the OCP2 catalytic behav-
iour compared to wild-type CBP and CDP, their structures and
sequences have been analysed in more detail. The five OCP2
mutations are all located in (close vicinity of) the catalytic cleft
(Fig. 6c). Previous experiments have demonstrated that only
two mutations, T508I and N667A, are needed to introduce
synthetic activity on cellobiose (De Groeve et al. 2010a).
Residue N667 is located at subsite − 1, and its substitution
with Ala introduces the residue that is present in CDPs, thus
making CBP more similar to the elongating enzymes (Fig. 5).
In turn, T508 is part of a loop (N495-E509) that is present in
CBPs but absent in CDPs, and blocks subsites + 2/+3 (Fig. 5,
Fig. 6). Its substitution with Ile seems to move the loop closer
to the + 3 subsite and block it evenmore (Fig. 6a). At the same
time, the side chain of Q506 is turned inwards to form hydro-
gen bonds with the glucose ring in subsite +2, thus improving
the binding of cellobiose as acceptor (Fig. 6a–c). Although
less crucial, two of the additional mutations make the active
site of OCP2 more similar to that of CDP. On the one hand,
the E649G substitution could mimic the Ala present in CDP to
create more space for cellobiose in subsite + 2 (Fig. 6c). On
the other hand, the N163D substitution introduces the Asp
residue present in CDP and further enhances the similarity
of its subsite + 2 (Fig. 5).
Despite the obvious preference towards cellotriose synthe-
sis, the OCP2 variant demonstrated a very low activity
(0.04 U/mg) and low affinity (Km of 10.2 mM) for the accep-
tor cellobiose. Further engineering efforts yielded the
OCP2_M52R variant with a fourfold lower Km for cellobiose
and fourfold higher activity. Furthermore, this variant also
offers a higher cellotriose yield (73 instead of 62%) and a drop
in further elongation (from 5 to 2%), thus giving an improved
product purity compared to the OCP2 starting point.
Remarkably, both variants exhibit a higher affinity for cello-
biose compared to glucose, which is unusual, considering that
glucose is the natural acceptor for CBP. However,
Fig. 6 Several homology models with docked cellotetraose coloured in
dark blue (+3 subsite) and red (− 1, + 1 and + 2 subsites). aOCP2(M52R)
superimposed with CuCBP and the impact of T508I indicated with
arrows. b CuCBP with an active site that is closed for larger acceptors.
cOCP2 in which the structural changes imposed by T508I and E649G are
shown. dOCP2_M52R inwhich the loopmoved inwards to further block
the subsite +3
Fig. 5 Multiple sequence alignment of selected GH94 enzymes. Highly
conserved residues that build up subsites − 1/+ 1 are represented in cyan
blue. The residues that build up subsites + 2/+ 3 in CDPs are represented
in purple. The five mutations in OCP2 are represented in yellow, while
the newly introduced M52R mutation is represented in green
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OCP2_M52R has a twofold lower Km for cellobiose com-
pared to cellotriose, while OCP2 exhibits the opposite trend,
and this could be one of the main reasons for the improved
performance in cellotriose production. In the homologymodel
of OCP2_M52R, the newly introduced Arg can be seen
blocking subsite +3 through interactions with Glu503 and
Asp156 (Fig. 6d).
Based on the conditions considered in this work, scale-up
of the process to 27 L with ~ 190 g of OCP2_M52R crude cell
extract would yield 1 kg of cellotriose starting from 0.92 kg of
cellobiose and 4.3 kg of αG1-P (disodium salt tetrahydrate).
The phosphate species could then be removed with an ion-
exchange resin (Van Der Borght et al. 2010) to obtain
cellotriose at a purity of 82%. Since the enzyme variant is
derived from CBP, it is also able to use glucose as acceptor.
In that case, 0.58 kg of glucose would be needed in a volume
of 32 L, with ~ 225 g of the enzyme crude cell extract. The
remaining acceptor could afterwards be removed by selective
fermentation (Yoon et al. 2003) to obtain cellotriose at a purity
of 62%. Furthermore, if αG1-P is to be regenerated through
coupling with sucrose phosphorylase, the fructose released
from sucrose could be converted to glucose as the required
acceptor substrate with the help of glucose isomerase. Overall,
the improved enzyme variant reported here should be a crucial
step in enabling further research on and commercial exploita-
tion of cellotriose.
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